美国 · SEC FORM 4
IRONWOOD PHARMACEUTICALS INC
IRWD · Nasdaq · CIK 0001446847 · Healthcare · Drug Manufacturers—Specialty & Generic
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
13 同一窗口内观察到的 Form 4 交易行
2 sales · 11 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号?
评分构成
活跃窗口内没有合资格买入,因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数?
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示,不会形成负分。
卖出和其他 Form 4 活动会单独显示,不会形成负面买入信号。没有买入不会被评分为看空。
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后,这些模块才会启用。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型;卖出仅作为背景。
Showing the six most active owners; 3 additional owner(s) remain in Form 4 申报证据.
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2024-03-06 · Duane Jon R.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据,不影响内部人信号。
- 空头股数
- 15,567,942
- 上期报告
- 18,728,986
- 日均成交量
- 2,515,801
- 回补天数
- 6.2
FINRA 结算日:2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数,每月两个结算日之后约一周公布;不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2024-03-06 | Duane Jon R | 买入 (P) | Class A Common Stock | 6,920 | USD 8.70 | USD 60,204 | SEC 申报 ↗ |
| 2024-03-04 | Emany Sravan Kumar | 买入 (P) | Class A Common Stock | 10,684 | USD 9.38 | USD 100,216 | SEC 申报 ↗ |
| 2023-09-15 | Emany Sravan Kumar | 买入 (P) | Class A Common Stock | 36,072 | USD 8.32 | USD 300,119 | SEC 申报 ↗ |
| 2021-03-10 | DENNER ALEXANDER J; Sarissa Capital Management LP | 买入 (P) | Class A Common Stock | 75,000 | USD 10.54 | USD 790,500 | SEC 申报 ↗ |
| 2021-03-08 | DENNER ALEXANDER J; Sarissa Capital Management LP | 买入 (P) | Class A Common Stock | 150,000 | USD 10.30 | USD 1,545,000 | SEC 申报 ↗ |
| 2021-03-05 | DENNER ALEXANDER J; Sarissa Capital Management LP | 买入 (P) | Class A Common Stock | 175,000 | USD 10.01 | USD 1,751,750 | SEC 申报 ↗ |
| 2021-03-04 | DENNER ALEXANDER J; Sarissa Capital Management LP | 买入 (P) | Class A Common Stock | 250,000 | USD 10.00 | USD 2,500,000 | SEC 申报 ↗ |
| 2021-03-03 | DENNER ALEXANDER J; Sarissa Capital Management LP | 买入 (P) | Class A Common Stock | 350,000 | USD 10.02 | USD 3,507,000 | SEC 申报 ↗ |
| 2021-03-02 | DENNER ALEXANDER J | 买入 (P) | Class A Common Stock | 500,000 | USD 9.56 | USD 4,780,000 | SEC 申报 ↗ |
| 2021-03-01 | DENNER ALEXANDER J | 买入 (P) | Class A Common Stock | 344,900 | USD 9.60 | USD 3,311,040 | SEC 申报 ↗ |
| 2021-02-26 | Owens Edward P | 买入 (P) | Class A Common Stock | 3,000 | USD 8.90 | USD 26,700 | SEC 申报 ↗ |
| 2021-02-26 | DENNER ALEXANDER J | 买入 (P) | Class A Common Stock | 505,100 | USD 9.20 | USD 4,646,920 | SEC 申报 ↗ |
| 2021-02-25 | Owens Edward P | 买入 (P) | Class A Common Stock | 5,000 | USD 9.11 | USD 45,550 | SEC 申报 ↗ |
| 2021-02-24 | Owens Edward P | 买入 (P) | Class A Common Stock | 7,000 | USD 9.26 | USD 64,820 | SEC 申报 ↗ |
Form 4 申报证据
37 transaction lines in the latest 365-day window; 396 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-15 | DENNER ALEXANDER J | 奖励/授予 (A) | Class A Common Stock | 3,694 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-20 | Silber Jeffrey | 奖励/授予 (A) | Class A Common Stock | 137,036 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-07 | Silver Ronald | 卖出 (S) | Class A Common Stock | 127,890 | USD 4.52 | USD 578,063 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-15 | DENNER ALEXANDER J | 奖励/授予 (A) | Class A Common Stock | 3,694 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-20 | Silber Jeffrey | 奖励/授予 (A) | Class A Common Stock | 137,036 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-07 | Silver Ronald | 卖出 (S) | Class A Common Stock | 127,890 | USD 4.52 | USD 578,063 | SEC 申报 ↗ |
| 2026-06-16 | Shepard Jay | 奖励/授予 (A) | Class A Common Stock | 63,481 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-16 | Moukheibir Catherine | 奖励/授予 (A) | Class A Common Stock | 63,481 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-16 | McHugh Julie | 卖出 (S) | Class A Common Stock | 21,571 | USD 3.73 | USD 80,460 | SEC 申报 ↗ |
| 2026-06-16 | McHugh Julie | 奖励/授予 (A) | Class A Common Stock | 63,481 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-16 | Kessler Marla L | 奖励/授予 (A) | Class A Common Stock | 63,481 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-16 | Duane Jon R | 奖励/授予 (A) | Class A Common Stock | 63,481 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-16 | DENNER ALEXANDER J | 奖励/授予 (A) | Class A Common Stock | 63,481 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-16 | Currie Mark G | 奖励/授予 (A) | Class A Common Stock | 63,481 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-15 | DENNER ALEXANDER J | 奖励/授予 (A) | Class A Common Stock | 4,065 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-19 | Silver Ronald | 奖励/授予 (A) | Common Stock | 25,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-17 | DENNER ALEXANDER J | 卖出 (S) | Class A Common Stock | 6,730,800 | USD 3.05 | USD 20,530,448 | SEC 申报 ↗ |
| 2026-03-13 | DENNER ALEXANDER J | 奖励/授予 (A) | Class A Common Stock | 4,451 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-10 | Silver Ronald | 奖励/授予 (A) | Class A Common Stock | 163,934 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-10 | Shetzline Michael | 奖励/授予 (A) | Class A Common Stock | 136,612 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-10 | Martini Gregory S. | 奖励/授予 (A) | Class A Common Stock | 136,612 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-10 | MCCOURT Thomas A | 奖励/授予 (A) | Class A Common Stock | 409,836 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-10 | John Minardo | 奖励/授予 (A) | Class A Common Stock | 136,612 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-10 | Gaskins Tammi L | 奖励/授予 (A) | Class A Common Stock | 136,612 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-24 | Silver Ronald | 卖出 (S) | Class A Common Stock | 12,621 | USD 3.66 | USD 46,193 | SEC 申报 ↗ |
| 2026-02-24 | Shetzline Michael | 卖出 (S) | Common Stock | 17,012 | USD 3.66 | USD 62,264 | SEC 申报 ↗ |
| 2026-02-24 | Martini Gregory S. | 卖出 (S) | Class A Common Stock | 11,457 | USD 3.66 | USD 41,933 | SEC 申报 ↗ |
| 2026-02-24 | MCCOURT Thomas A | 卖出 (S) | Class A Common Stock | 103,526 | USD 3.66 | USD 378,905 | SEC 申报 ↗ |
| 2026-02-24 | John Minardo | 卖出 (S) | Class A Common Stock | 19,053 | USD 3.66 | USD 69,734 | SEC 申报 ↗ |
| 2026-02-24 | Gaskins Tammi L | 卖出 (S) | Class A Common Stock | 11,239 | USD 3.66 | USD 41,135 | SEC 申报 ↗ |
| 2026-02-23 | Silver Ronald | 卖出 (S) | Class A Common Stock | 11,552 | USD 3.81 | USD 44,013 | SEC 申报 ↗ |
| 2026-02-23 | Shetzline Michael | 卖出 (S) | Class A Common Stock | 15,570 | USD 3.81 | USD 59,322 | SEC 申报 ↗ |
| 2026-02-23 | Martini Gregory S. | 卖出 (S) | Class A Common Stock | 10,487 | USD 3.81 | USD 39,955 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-19 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | IRWD |
| CIK | 0001446847 |
| 行业 | Healthcare |
| 细分行业 | Drug Manufacturers—Specialty & Generic Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 396 transaction lines from 2020-01-16 to 2026-09-15 14 P purchase lines · 196 S sale lines · 186 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-19. Mapping status is an audit field and does not erase SEC filing evidence.